Steven Wheen
Stock Analyst at Jarden
(3.85)
# 1,831
Out of 4,345 analysts
226
Total ratings
45.7%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Steven Wheen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: HLS Healius Limited | Maintained: Sell | $0.77 → $0.47 | $0.35 | +34.29% | 32 | May 14, 2026 | |
| ASX: CSL CSL Limited | Downgraded: Hold | $244.00 → $191.00 | $97.80 | +95.31% | 33 | May 12, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | $44.80 → $42.70 | $29.21 | +46.18% | 21 | May 2, 2026 | |
| ASX: REG Regis Healthcare Limited | Maintained: Buy | $8.50 | $6.53 | +30.27% | 15 | Apr 23, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Hold | $224.00 → $169.00 | $97.36 | +73.58% | 16 | Apr 22, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $21.00 → $21.80 | $13.73 | +58.78% | 29 | Apr 7, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Buy | $40.60 → $45.20 | $37.23 | +21.41% | 25 | Feb 27, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.35 → $3.25 | $2.08 | +56.25% | 23 | Feb 25, 2026 | |
| ASX: QUB Qube Holdings Limited | Maintained: Hold | $5.00 | $5.02 | -0.30% | 1 | Feb 20, 2026 | |
| ASX: QBE QBE Insurance Group Limited | Maintained: Hold | $22.00 | $22.99 | -4.31% | 1 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26.27 → $21.90 | $18.72 | +17.02% | 28 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.71 → $0.75 | $0.64 | n/a | 2 | Nov 27, 2024 |
Healius Limited
May 14, 2026
Maintained: Sell
Price Target: $0.77 → $0.47
Current: $0.35
Upside: +34.29%
CSL Limited
May 12, 2026
Downgraded: Hold
Price Target: $244.00 → $191.00
Current: $97.80
Upside: +95.31%
ResMed Inc.
May 2, 2026
Maintained: Buy
Price Target: $44.80 → $42.70
Current: $29.21
Upside: +46.18%
Regis Healthcare Limited
Apr 23, 2026
Maintained: Buy
Price Target: $8.50
Current: $6.53
Upside: +30.27%
Cochlear Limited
Apr 22, 2026
Maintained: Hold
Price Target: $224.00 → $169.00
Current: $97.36
Upside: +73.58%
Telix Pharmaceuticals Limited
Apr 7, 2026
Maintained: Buy
Price Target: $21.00 → $21.80
Current: $13.73
Upside: +58.78%
Ramsay Health Care Limited
Feb 27, 2026
Maintained: Buy
Price Target: $40.60 → $45.20
Current: $37.23
Upside: +21.41%
Integral Diagnostics Limited
Feb 25, 2026
Maintained: Buy
Price Target: $3.35 → $3.25
Current: $2.08
Upside: +56.25%
Qube Holdings Limited
Feb 20, 2026
Maintained: Hold
Price Target: $5.00
Current: $5.02
Upside: -0.30%
QBE Insurance Group Limited
Feb 20, 2026
Maintained: Hold
Price Target: $22.00
Current: $22.99
Upside: -4.31%
Feb 20, 2026
Maintained: Hold
Price Target: $26.27 → $21.90
Current: $18.72
Upside: +17.02%
Nov 27, 2024
Maintained: Hold
Price Target: $0.71 → $0.75
Current: $0.64
Upside: n/a